Sagimet Biosciences (SGMT) Change in Acquisitions & Divestments (2022 - 2026)

Sagimet Biosciences' Change in Acquisitions & Divestments history spans 5 years, with the latest figure at $17.0 million for Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 10.64% to $17.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $109.4 million through Mar 2026, up 75.34% year-over-year, with the annual reading at $111.4 million for FY2025, 140.11% up from the prior year.
  • Change in Acquisitions & Divestments came in at $17.0 million for Q1 2026, down from $31.4 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $31.4 million in Q4 2025 to a low of $3.0 million in Q1 2024.
  • The 5-year median for Change in Acquisitions & Divestments is $18.0 million (2025), against an average of $17.7 million.
  • Year-over-year, Change in Acquisitions & Divestments crashed 84.54% in 2024 and then surged 532.93% in 2025.
  • Sagimet Biosciences' Change in Acquisitions & Divestments stood at $5.4 million in 2022, then skyrocketed by 135.47% to $12.8 million in 2023, then skyrocketed by 84.44% to $23.6 million in 2024, then skyrocketed by 33.15% to $31.4 million in 2025, then tumbled by 46.02% to $17.0 million in 2026.
  • Per Business Quant, the three most recent readings for SGMT's Change in Acquisitions & Divestments are $17.0 million (Q1 2026), $31.4 million (Q4 2025), and $31.3 million (Q3 2025).